D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
Halliburton
HAL
$27.9B
| $45.2M | 0.06% |
1,543,300
+663,200
| +75% | +$20M |
|
402
PUT
JD.com
JD
$40.8B
| $45.2M | 0.06% |
1,497,900
-3,740,500
| -71% | -$95.1M |
|
|
SMAR
403
DELISTED
Smartsheet Inc.
SMAR
| $45.1M | 0.06% |
+1,106,288
| New | +$38.2M |
|
404
Omeros
OMER
$709M
| $44.9M | 0.06% |
2,585,438
+673,194
| +35% | +$9.71M |
|
|
DLPH
405
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $44.7M | 0.06% |
2,322,437
+743,192
| +47% | +$13.7M |
|
406
PUT
FedEx
FDX
$74.5B
| $44.7M | 0.06% |
246,300
+122,200
| +98% | +$21.6M |
|
407
Pentair
PNR
$10.2B
| $44.6M | 0.06% |
1,001,483
+819,585
| +451% | +$34.1M |
|
408
InterDigital
IDCC
$6.68B
| $43.9M | 0.06% |
666,062
+147,832
| +29% | +$10.3M |
|
409
LKQ Corp
LKQ
$6.58B
| $43.9M | 0.06% |
1,547,897
-49,625
| -3% | -$1.34M |
|
410
Equity Lifestyle Properties
ELS
$12.8B
| $43.8M | 0.06% |
766,924
-240,160
| -24% | -$12.8M |
|
411
Ametek
AME
$55.5B
| $43.7M | 0.06% |
527,257
-35,833
| -6% | -$2.72M |
|
412
PUT
Coca-Cola
KO
$354B
| $43.7M | 0.06% |
932,000
+667,900
| +253% | +$31.2M |
|
413
PUT
JPMorgan Chase
JPM
$939B
| $43.6M | 0.06% |
430,300
-620,200
| -59% | -$63.9M |
|
|
BERY
414
DELISTED
Berry Global Group, Inc.
BERY
| $43.2M | 0.06% |
872,970
+189,638
| +28% | +$8.99M |
|
415
Northrop Grumman
NOC
$77B
| $43.1M | 0.06% |
159,806
+133,891
| +517% | +$36.5M |
|
|
NBIS
416
Nebius Group N.V.
NBIS
$47.7B
| $42.7M | 0.06% |
+1,243,235
| New | +$41.2M |
|
417
iShares Core S&P 500 ETF
IVV
$876B
| $42.7M | 0.06% |
150,000
| – | – |
|
|
K
418
DELISTED
Kellanova
K
| $42.5M | 0.06% |
789,371
+708,229
| +873% | +$37.8M |
|
|
MDRX
419
DELISTED
Veradigm Inc. Common Stock
MDRX
| $42.2M | 0.05% |
4,424,985
+1,035,753
| +31% | +$11.4M |
|
420
CALL
Cisco
CSCO
$450B
| $42.2M | 0.05% |
780,800
-262,200
| -25% | -$12.7M |
|
421
Voya Financial
VOYA
$8.94B
| $42.1M | 0.05% |
842,276
-189,545
| -18% | -$8.99M |
|
|
TVTY
422
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $42.1M | 0.05% |
2,396,146
+792,315
| +49% | +$16.9M |
|
|
423
JD.com
JD
$40.8B
| $42M | 0.05% |
1,394,478
-1,890,892
| -58% | -$48.1M |
|
424
Nasdaq
NDAQ
$51.5B
| $41.9M | 0.05% |
1,437,621
-1,939,887
| -57% | -$55.3M |
|
425
Toll Brothers
TOL
$14B
| $41.9M | 0.05% |
1,157,584
+349,831
| +43% | +$12.6M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.